Dynapar AQ Injection 1ml
In Stock • people bought this
- Fast relief from musculoskeletal pain
- Reduces inflammation effectively
- Ideal for postoperative recovery
- Rapid action for acute conditions
Delivery : 2-4 days PAN India
Seller : Davadost pharma private limited
Similar Medicine Of
Discover the Benefits of ABHA Card registration
Simplify your healthcare journey with Indian Government's ABHA card. Get your card today!
Create ABHAIntroduction to
Dynapar AQ Injection 1ml is a potent non-steroidal anti-inflammatory drug (NSAID) designed to alleviate pain and reduce inflammation in various acute and chronic conditions. Its active ingredient, diclofenac sodium, is renowned for its efficacy in managing pain associated with musculoskeletal disorders, postoperative recovery, and other inflammatory conditions.
Diclofenac sodium functions by inhibiting the cyclooxygenase (COX) enzymes, specifically COX-1 and COX-2. These enzymes play a pivotal role in the biosynthesis of prostaglandins, which are lipid compounds that mediate inflammation and pain. By suppressing prostaglandin production, Dynapar AQ effectively diminishes inflammation and provides relief from pain.
- Intramuscular Injection (IM): Dynapar AQ Injection 1ml should be used deeply into the gluteal muscle.
- Intravenous Injection (IV): It should be injected as a slow bolus injection.
- Inform your healthcare provider if you have a history of gastrointestinal disorders, such as ulcers or bleeding.
- Inform your healthcare provider if you have Cardiovascular conditions, including hypertension or heart failure.
- Inform your healthcare provider if you have Kidney or liver impairments.
- Inform your healthcare provider if you have Asthma or other respiratory issues.
- Inform your healthcare provider if you have known hypersensitivity to diclofenac or other NSAIDs.
- Dynapar AQ Injection offers rapid and effective relief from Acute musculoskeletal pain.
- It also offers relief from Postoperative pain.
- It also support in pain from renal colic (kidney stones).
- Inform your healthcare provider if you have exacerbations of osteoarthritis and rheumatoid arthritis.
- Its injectable form ensures swift onset of action, making it suitable for situations where oral administration is not feasible or when rapid pain control is desired.
- Common side effects may include: Injection site reactions (pain, swelling, redness), Nausea or vomiting, Headache, Dizziness, Elevated blood pressure.
- Seek immediate medical attention if you experience symptoms such as chest pain, shortness of breath, unilateral weakness, slurred speech, or swelling.
- As Dynapar AQ Injection is typically administered in a clinical setting by healthcare professionals, missing a dose is unlikely.
- If a scheduled dose is missed, consult with your healthcare provider promptly.
Health And Lifestyle
- Anticoagulants: Increased risk of bleeding.
- Other NSAIDs or corticosteroids: Heightened risk of gastrointestinal issues.
- Antihypertensives: Potential reduction in blood pressure control efficacy.
- Diuretics: Possible decreased effectiveness.
- While specific food interactions with Dynapar AQ Injection are not well-documented, it's advisable to avoid alcohol during treatment, as it can increase the risk of gastrointestinal bleeding.
Dynapar AQ Injection is utilized in managing conditions characterized by pain and inflammation, such as: Rheumatoid Arthritis: An autoimmune disorder causing joint inflammation. Osteoarthritis: Degeneration of joint cartilage leading to pain and stiffness. Ankylosing Spondylitis: Inflammation of the spine and large joints. Acute Musculoskeletal Injuries: Injuries causing immediate pain and swelling.
Safety Advice For
- High risk
- Moderate risk
- Safe
Dose adjustment is required before taking this drug.
You should take precaution during taking this drug.
It will increase drawsiness.
It can affect your driving ability.
Individual should take healthcare professional instructions.
It is not recommended during breast feeding.
- Adhere strictly to the prescribed Dynapar AQ Injection dosage and administration schedule.
- Report any unusual symptoms or side effects to your healthcare provider promptly.
- Avoid operating heavy machinery or driving if you experience dizziness or drowsiness post-injection.
- Chemical Class: Phenylacetic acid derivative.
- Habit Forming: No.
- Therapeutic Class: Analgesics and anti-inflammatory agents.
- Store Dynapar AQ Injection at room temperature (below 30°C), protected from light and moisture. Keep out of reach of children.
- The typical dosage of Dynapar AQ is 75 mg administered either intramuscularly or intravenously, depending on the patient's condition and the healthcare provider's judgment.
- The duration of treatment should be as short as possible to minimize potential side effects.
Dynapar AQ 75 mg Injection 1 ml is a fast-acting NSAID effective in managing various painful and inflammatory conditions. It contains diclofenac sodium, which works by inhibiting prostaglandin synthesis, thus reducing inflammation and pain. It is commonly used for musculoskeletal pain, postoperative pain, and other acute conditions requiring rapid relief.
What is Dynapar AQ Injection used for?
How quickly does Dynapar AQ Injection work?
Can Dynapar AQ Injection be self-administered?
Are there any age restrictions for using Dynapar AQ Injection?
Can I take oral painkillers along with Dynapar AQ Injection?
Is Dynapar AQ Injection safe for long-term use?
What should I do if I experience an allergic reaction?
Can pregnant or breastfeeding women use Dynapar AQ Injection?
Does Dynapar AQ Injection cause drowsiness?
What should I do if I miss a dose?
Can Dynapar AQ Injection be used for migraines?
Does it interact with any specific foods?
Can diabetics take Dynapar AQ Injection?
Does Dynapar AQ affect kidney function?
Can this injection cause high blood pressure?
Is it safe for individuals with asthma?
How should Dynapar AQ Injection be stored?
Can this injection be used for dental pain?
Is Dynapar AQ habit-forming?
What precautions should I take while using Dynapar AQ Injection?
Written By
Nish Kumar
B.Pharma + MBA
Content Updated on
Friday, 13 Feburary, 2026
